Pfizer vaccine 95% effective in final analysis, company seeks final safety step | WNT

  • By cvbizz
  • November 19, 2020
  • 0
  • 9 Views
Share This Post!

Pfizer and partner BioNTech said Wednesday the company will apply for FDA emergency authorization “within days,” following the promising final analysis of the Phase 3 trial.


Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com